INTRODUCTION: Studies on biomarkers in tuberculosis are focused on pulmonary forms of this disease (PTB), and only limited information is currently available on biomarkers of extra-pulmonary tuberculosis (EPTB). METHODS: Serum samples from 24 patients with PTB, 29 patients with EPTB and 27 healthy controls were obtained, and the levels of interferon-gamma, chemokine ligand 9, mannose-binding lectin (MBL), tumor marker Ca-125 and adenosine deaminase were determined. RESULTS: The circulating levels of all tested biomarkers in the serum were significantly higher in PTB and EPTB patients than in controls. However, there were no significant differences in the levels of the biomarkers between patients with PTB and EPTB, with the exception of serum levels of MBL which were significantly higher in patients with EPTB than in patients with PTB (p = 0.01). In patients with EPTB, no significant differences were observed in biomarker levels among patients with or without concomitant PTB involvement. Based on MBL serum levels, ROC curve analysis showed an AUC of 0.85 for EPTB versus non-EPTB. The optimal cut-off value of MBL serum levels for EPTB versus non-EPTB was 1,000 μg/ml, with a sensitivity and specificity of 79.3 and 78.0 %, respectively. CONCLUSIONS: Biomarkers usually present as acute phase reactants and do not enable pulmonary forms to be differentiated from more serious or extra-pulmonary forms. MBL may be an exception.
INTRODUCTION: Studies on biomarkers in tuberculosis are focused on pulmonary forms of this disease (PTB), and only limited information is currently available on biomarkers of extra-pulmonary tuberculosis (EPTB). METHODS: Serum samples from 24 patients with PTB, 29 patients with EPTB and 27 healthy controls were obtained, and the levels of interferon-gamma, chemokine ligand 9, mannose-binding lectin (MBL), tumor marker Ca-125 and adenosine deaminase were determined. RESULTS: The circulating levels of all tested biomarkers in the serum were significantly higher in PTB and EPTB patients than in controls. However, there were no significant differences in the levels of the biomarkers between patients with PTB and EPTB, with the exception of serum levels of MBL which were significantly higher in patients with EPTB than in patients with PTB (p = 0.01). In patients with EPTB, no significant differences were observed in biomarker levels among patients with or without concomitant PTB involvement. Based on MBL serum levels, ROC curve analysis showed an AUC of 0.85 for EPTB versus non-EPTB. The optimal cut-off value of MBL serum levels for EPTB versus non-EPTB was 1,000 μg/ml, with a sensitivity and specificity of 79.3 and 78.0 %, respectively. CONCLUSIONS: Biomarkers usually present as acute phase reactants and do not enable pulmonary forms to be differentiated from more serious or extra-pulmonary forms. MBL may be an exception.
Authors: A Verbon; N Juffermans; S J Van Deventer; P Speelman; H Van Deutekom; T Van Der Poll Journal: Clin Exp Immunol Date: 1999-01 Impact factor: 4.330
Authors: F Ameglio; D Giannarelli; P Cordiali-Fei; M Pietravalle; L Alemanno; G Paone; M Amicosante; C Saltini; A Bisetti Journal: Am J Clin Pathol Date: 1994-06 Impact factor: 2.493
Authors: H Cosar; F Ozkinay; H Onay; N Bayram; A R Bakiler; M Anil; D Can; C Ozkinay Journal: Eur J Clin Microbiol Infect Dis Date: 2008-07-09 Impact factor: 3.267
Authors: Heather M Peto; Robert H Pratt; Theresa A Harrington; Philip A LoBue; Lori R Armstrong Journal: Clin Infect Dis Date: 2009-11-01 Impact factor: 9.079
Authors: J Fortún; P Martín-Dávila; R Méndez; A Martínez; F Norman; J Rubi; E Pallares; E Gómez-Mampaso; S Moreno Journal: Open Respir Med J Date: 2009-11-20
Authors: Jorge Parra-Ruiz; V Ramos; C Dueñas; N M Coronado-Álvarez; R Cabo-Magadán; V Portillo-Tuñón; D Vinuesa; L Muñoz-Medina; J Hernández-Quero Journal: Infection Date: 2015-04-14 Impact factor: 3.553
Authors: Bih H Chendi; Candice I Snyders; Kristian Tonby; Synne Jenum; Martin Kidd; Gerhard Walzl; Novel N Chegou; Anne M Dyrhol-Riise Journal: Front Immunol Date: 2021-02-24 Impact factor: 7.561